A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants
Clinical trial NCT06673927 · COMPLETED
Trial details
- NCT number
- NCT06673927
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2018-11-21
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.